Literature DB >> 1347479

Tardive dyskinesia. Patients' lack of awareness of movement disorder.

R Macpherson1, R Collis.   

Abstract

Of 113 patients in long-stay wards of a psychiatric hospital, 43 had TD. Twenty-six of the 39 patients who consented to take part in the study were unaware of abnormal involuntary movements. These patients scored significantly lower on a short test of cognitive function than patients who were aware of such movements. The diagnosis of schizophrenia, particularly the 'defect' state with cognitive deficit and negative symptoms, was found to be associated with lack of awareness of TD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347479     DOI: 10.1192/bjp.160.1.110

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

Review 1.  Psychiatric stigma: past, passing and to come.

Authors:  P Byrne
Journal:  J R Soc Med       Date:  1997-11       Impact factor: 5.344

Review 2.  Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.

Authors:  Katharina Stegmayer; Sebastian Walther; Peter van Harten
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

3.  Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder.

Authors:  P Roberto Bakker; Izaäk W de Groot; Jim van Os; Peter N van Harten
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 4.  Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Marco Solmi; Giorgio Pigato; John M Kane; Christoph U Correll
Journal:  Drug Des Devel Ther       Date:  2018-05-14       Impact factor: 4.162

Review 5.  Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.

Authors:  Robert A Hauser; Jonathan M Meyer; Stewart A Factor; Cynthia L Comella; Caroline M Tanner; Rose Mary Xavier; Stanley N Caroff; Leslie Lundt
Journal:  CNS Spectr       Date:  2020-11-20       Impact factor: 4.604

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.